This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coconnier, M.-H.
Right arrow Articles by Servin, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coconnier, M.-H.
Right arrow Articles by Servin, A. L.
Agricola
Right arrow Articles by Coconnier, M.-H.
Right arrow Articles by Servin, A. L.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, November 1998, p. 4573-4580, Vol. 64, No. 11
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Antagonistic Activity against Helicobacter Infection In Vitro and In Vivo by the Human Lactobacillus acidophilus Strain LB

Marie-Helene Coconnier,1 Vanessa Lievin,1 Elisabeth Hemery,2 and Alain L. Servin1,*

Institut National de la Santé et de la Recherche Médicale, CJF 94.07, UFR de Pharmacie, Université Paris XI, F-92296 Châtenay-Malabry,1 and Anatomie Pathologie A, Centre Hospitalier Universitaire de Nantes, F-44000 Nantes,2 France

Received 17 March 1998/Accepted 12 August 1998

The purpose of the present study was to examine the activity of the human Lactobacillus acidophilus strain LB, which secretes an antibacterial substance(s) against Helicobacter pylori in vitro and in vivo. The spent culture supernatant (SCS) of the strain LB (LB-SCS) dramatically decreased the viability of H. pylori in vitro independent of pH and lactic acid levels. Adhesion of H. pylori to the cultured human mucosecreting HT29-MTX cells decreased in parallel with the viability of H. pylori. In conventional mice, oral treatment with the LB-SCS protected against infection with Helicobacter felis. Indeed, at both 8 and 49 days post-LB-SCS treatment (29 and 70 days postinfection), inhibition of stomach colonization by H. felis was observed, and no evidence of gastric histopathological lesions was found. LB-SCS treatment inhibits the H. pylori urease activity in vitro and in H. pylori that remained associated with the cultured human mucosecreting HT29-MTX cells. Moreover, a decrease in urease activity was detected in the stomach of the mice infected with H. felis and treated with LB-SCS.


* Corresponding author. Mailing address: UPS Faculté de Pharmacie Paris XI, CJF 94.07, INSERM, F-92296 Châtenay-Malabry, France. Phone and fax: 33.1.46.83.56.61. E-mail: alain.servin{at}cep.u-psud.fr.


Applied and Environmental Microbiology, November 1998, p. 4573-4580, Vol. 64, No. 11
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Haesebrouck, F., Pasmans, F., Flahou, B., Chiers, K., Baele, M., Meyns, T., Decostere, A., Ducatelle, R. (2009). Gastric Helicobacters in Domestic Animals and Nonhuman Primates and Their Significance for Human Health. Clin. Microbiol. Rev. 22: 202-223 [Abstract] [Full Text]  
  • Myllyluoma, E., Ahonen, A.-M., Korpela, R., Vapaatalo, H., Kankuri, E. (2008). Effects of Multispecies Probiotic Combination on Helicobacter pylori Infection In Vitro. CVI 15: 1472-1482 [Abstract] [Full Text]  
  • Galdeano, C. M., de Moreno de LeBlanc, A., Vinderola, G., Bonet, M. E. B., Perdigon, G. (2007). Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria. CVI 14: 485-492 [Full Text]  
  • Lesbros-Pantoflickova, D., Corthesy-Theulaz, I., Blum, A. L. (2007). Helicobacter pylori and Probiotics. J. Nutr. 137: 812S-818S [Abstract] [Full Text]  
  • Kusters, J. G., van Vliet, A. H. M., Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori Infection. Clin. Microbiol. Rev. 19: 449-490 [Abstract] [Full Text]  
  • Sheu, B.-S., Cheng, H.-C., Kao, A.-W., Wang, S.-T., Yang, Y.-J., Yang, H.-B., Wu, J.-J. (2006). Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.. Am. J. Clin. Nutr. 83: 864-869 [Abstract] [Full Text]  
  • Sgouras, D. N., Panayotopoulou, E. G., Martinez-Gonzalez, B., Petraki, K., Michopoulos, S., Mentis, A. (2005). Lactobacillus johnsonii La1 Attenuates Helicobacter pylori-Associated Gastritis and Reduces Levels of Proinflammatory Chemokines in C57BL/6 Mice. CVI 12: 1378-1386 [Abstract] [Full Text]  
  • Coconnier-Polter, M.-H., Lievin-Le Moal, V., Servin, A. L. (2005). A Lactobacillus acidophilus Strain of Human Gastrointestinal Microbiota Origin Elicits Killing of Enterovirulent Salmonella enterica Serovar Typhimurium by Triggering Lethal Bacterial Membrane Damage. Appl. Environ. Microbiol. 71: 6115-6120 [Abstract] [Full Text]  
  • Benyacoub, J., Perez, P. F., Rochat, F., Saudan, K. Y., Reuteler, G., Antille, N., Humen, M., De Antoni, G. L., Cavadini, C., Blum, S., Schiffrin, E. J. (2005). Enterococcus faecium SF68 Enhances the Immune Response to Giardia intestinalis in Mice. J. Nutr. 135: 1171-1176 [Abstract] [Full Text]  
  • Humen, M. A., De Antoni, G. L., Benyacoub, J., Costas, M. E., Cardozo, M. I., Kozubsky, L., Saudan, K.-Y., Boenzli-Bruand, A., Blum, S., Schiffrin, E. J., Perez, P. F. (2005). Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis In Vivo. Infect. Immun. 73: 1265-1269 [Abstract] [Full Text]  
  • Horie, K., Horie, N., Abdou, A. M., Yang, J.-O., Yun, S.-S., Chun, H.-N., Park, C.-K., Kim, M., Hatta, H. (2004). Suppressive Effect of Functional Drinking Yogurt Containing Specific Egg Yolk Immunoglobulin on Helicobacter pylori in Humans. J DAIRY SCI 87: 4073-4079 [Abstract] [Full Text]  
  • Wang, K.-Y., Li, S.-N., Liu, C.-S., Perng, D.-S., Su, Y.-C., Wu, D.-C., Jan, C.-M., Lai, C.-H., Wang, T.-N., Wang, W.-M. (2004). Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 80: 737-741 [Abstract] [Full Text]  
  • Adolfsson, O., Meydani, S. N., Russell, R. M (2004). Yogurt and gut function. Am. J. Clin. Nutr. 80: 245-256 [Abstract] [Full Text]  
  • Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E., Michopoulos, S., Kalantzopoulos, G., Tsakalidou, E., Mentis, A. (2004). In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota. Appl. Environ. Microbiol. 70: 518-526 [Abstract] [Full Text]  
  • Reid, G., Jass, J., Sebulsky, M. T., McCormick, J. K. (2003). Potential Uses of Probiotics in Clinical Practice. Clin. Microbiol. Rev. 16: 658-672 [Abstract] [Full Text]  
  • Gotteland, M., Cruchet, S. (2003). Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 51: 1317-1319 [Full Text]  
  • Nam, H., Ha, M., Bae, O., Lee, Y. (2002). Effect of Weissella confusa Strain PL9001 on the Adherence and Growth of Helicobacter pylori. Appl. Environ. Microbiol. 68: 4642-4645 [Abstract] [Full Text]  
  • Lievin-Le Moal, V, Amsellem, R, Servin, A L, Coconnier, M-H (2002). Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 50: 803-811 [Abstract] [Full Text]  
  • Pinchuk, I. V., Bressollier, P., Verneuil, B., Fenet, B., Sorokulova, I. B., Megraud, F., Urdaci, M. C. (2001). In Vitro Anti-Helicobacter pylori Activity of the Probiotic Strain Bacillus subtilis 3 Is Due to Secretion of Antibiotics. Antimicrob. Agents Chemother. 45: 3156-3161 [Abstract] [Full Text]  
  • Perez, P. F., Minnaard, J., Rouvet, M., Knabenhans, C., Brassart, D., De Antoni, G. L., Schiffrin, E. J. (2001). Inhibition of Giardia intestinalis by Extracellular Factors from Lactobacilli: an In Vitro Study. Appl. Environ. Microbiol. 67: 5037-5042 [Abstract] [Full Text]  
  • Lievin, V, Peiffer, I, Hudault, S, Rochat, F, Brassart, D, Neeser, J-R, Servin, A L (2000). Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47: 646-652 [Abstract] [Full Text]  
  • Gänzle, M. G., Höltzel, A., Walter, J., Jung, G., Hammes, W. P. (2000). Characterization of Reutericyclin Produced by Lactobacillus reuteri LTH2584. Appl. Environ. Microbiol. 66: 4325-4333 [Abstract] [Full Text]  
  • Coconnier, M.-H., Liévin, V., Lorrot, M., Servin, A. L. (2000). Antagonistic Activity of Lactobacillus acidophilus LB against Intracellular Salmonella enterica Serovar Typhimurium Infecting Human Enterocyte-Like Caco-2/TC-7 Cells. Appl. Environ. Microbiol. 66: 1152-1157 [Abstract] [Full Text]  
  • Sanders, M. E. (2000). Considerations for Use of Probiotic Bacteria to Modulate Human Health. J. Nutr. 130: 384-384 [Abstract] [Full Text]  
  • Jacobsen, C. N., Rosenfeldt Nielsen, V., Hayford, A. E., Møller, P. L., Michaelsen, K. F., Pærregaard, A., Sandström, B., Tvede, M., Jakobsen, M. (1999). Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans. Appl. Environ. Microbiol. 65: 4949-4956 [Abstract] [Full Text]